Evaluation of Genotype MTBDRsl Assay to Detect Drug Resistance Associated with Fluoroquinolones, Aminoglycosides and Ethambutol on Clinical Sediments

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Ajbani, Kanchan ^a   Nikam, Chaitali ^a   Kazi, Mubin ^a   Gray, Christen ^b   Boehme, Catharina ^b   Balan, Kavita ^a   Shetty, Anjali ^a   Rodrigues, Camilla ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

^b FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN; QUINOLONE DERIVATIVE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG RESISTANT TUBERCULOSIS; GENE; GENETIC LINKAGE; HUMAN; PREDICTIVE VALUE; PREVALENCE; RRS GENE; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM SMEAR; VALIDITY;

AMINOGLYCOSIDES; ANTITUBERCULAR AGENTS; BASE SEQUENCE; COMMUNICABLE DISEASE CONTROL; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; FLUOROQUINOLONES; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

NUCLEOPOLYHEDROVIRUS;

EID: 84869238709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049433     Document Type: Article

References (30)

1. Mistry NF, Iyer AM, D'souza DT, Taylor M, Young DB, et al. (2002) Spoligotyping of Mycobacterium tuberculosis Isolates from Multiple-Drug-Resistant Tuberculosis Patients from Bombay, India. Journal Of Clinical Microbiology, 40 (7): 2677-2680.
2. Jassal M, Bishai WR, (2009) Extensively drug-resistant tuberculosis, Lancet Infect Diseases. 9: 19-30.
3. Parsons LM, Somoskovi A, Gutierrez C, Lee E, Paramasivan CN, et al. (2011) Laboratory Diagnosis of Tuberculosis in Resource -Poor countries: Challenges and Opportunities. Clinical Microbiology Reviews 24(2): 314-350.
4. World Health Orginisation. Policy guideline: Molecular Line Probe Assays for Rapid Screening of Patients of Multidrug resistant tuberculosis. Geneva: World Health Orginisation, 2008. Available: www.who.int/tb/laboratory/line_probe_assays/en. Accessed: July 05 2012.
5. Maruri F, Sterling TR, Kaiga AW, Blackman A, Van der Heijden YF, et al. (2012) A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. Journal of Antimicrob Chemother 67(4): 819-831.
6. Jugheli L, Bzekalava N, Rijk P, Fissette K, Portaels F, et al. (2009) High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs Gene. Antimicrobial Agents And Chemotherapy, 53 (12): 5064-5068.
7. Zhang Y, Yew WW, (2009) Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13(11): 1320-1330.
8. World Health Orginisation (2008) Policy guideline on drug susceptibility testing (DST) of second line antimicrobial drugs Geneva: World Health Orginisation, 2008.
9. World Health Organization (1997) Treatment of Tuberculosis: Guidelines for national programmes, 2nd ed. WHO/TB/97.220, Geneva, 1997.
10. Rodrigues C, Almedia D, Shenai S, Goyal N, Mehta A (2007) Dedicated decontamination: A necessity to prevent cross-contamination in High throughput Mycobacteriology Laboratories. Indian Journal of Medical Microbiology, 25(1), 4-6.
11. Rodrigues C, Jani J, Shenai S, Thakkar P, Siddiqi S, et al. (2008) Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. International Journal of tuberculosis and Lung diseases 12(12): 1449-1455.
12. Hain Life science Kit inserts for MTBDRsl (Version 1), IFU: 3XX-XX., Available: www.hain-lifescience.de/en/Accessed: July 05 2012.
13. Hillemann D, Rüsch-Gerdes S, Richter E, (2009) Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens. Journal Of Clinical Microbiology 47(6): 1767-1772.
14. Miotto P, Cabibbe A, Mantegani P, Borroni E, Fattorini L, et al. (2012) Genotype MTBDRsl performance on clinical samples with diverse genetic background. European respiratory journal, In press.
15. Lacoma A, Garcia-Sierra N, Part C, Maldonado J, Ruiz-Manzano J, et al. (2012) Genotype MTBDrsl for molecular detection of second line drug and ethambutol resistance in Mycobacterium tuberculosis. Journal of Clinical Microbiology, 50 (1): 30-36.
16. Ignatyeva O, Kontsevaya I, Kovalyov A, Balabanova Y, Nikolayevskyy V, et al. (2012) Detection of resistance to second-line antituberculosis drugs using the Genotype® MTBDRsl assay: a multi-center evaluation and feasibility study. J. Clin. Microbiol., In press.
17. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W, (2010) Detection by genotype MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug- Resistant Mycobacterium tuberculosis Complex Isolate. Journal Of Clinical Microbiology 48(5): 1683-1689.
18. Huang WL, Chi TL, Wu MH, Jou R, (2011) Performance Assessment of the GenoType MTBDRsl Test and DNA Sequencing for Detection of Second-Line and Ethambutol Drug Resistance among Patients Infected with Multidrug-Resistant Mycobacterium tuberculosis. Journal Of Clinical Microbiology 49(7): 2502-2508.
19. Kiet V, Lan NT, An DD, Dung NH, Hoa DV, et al. (2010) Evaluation Of The MTBDRsl Test For Detection Of Second-Line-Drug Resistance In Mycobacterium Tuberculosis. Journal Of Clinical Microbiology, 48 (8): 2934-2939.
20. Chakravorty S, Aladegbami B, Thomas K, Lee JS, Lee EG, (2011) Rapid detection of Fluroquinolone-Resistant and Heteroresistant Mycobacterium tuberculosis by use of Sloppy Molecular Becons and Dual Melting-Temperature Codes in a Real Time PCR assay. Journal of Clinical Microbiology 49(3): 932-940.
21. Shen GH, Tsao TC, Kao SJ, Lee JJ, Chen YH, et al. (2012) Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions. International Journal of Antimicrobial Agents 39(3): 201-205.
22. Alangaden G, Kreiswirth B, Aouad A, Khetarpal M, Igno F, et al. (1998) Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis. Antimicrobial Agents And Chemotherapy 42(5): 1295-1297.
23. Shrivastava S, Garg A, Ayyagari A, Nyati KK, Dhole TN, et al. (2006) Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis. Current microbiology 53: 401-405.
24. Johnson R, Jordaan AM, Pretorius L, Engelke E, Van dar Spuy G, et al. (2006) Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 10(1): 68-73.
25. Plinke C, Cox HS, Kalon S, Doshetov D, Rüsch-Gerdes S, et al. (2009) Tuberculosis ethambutol resistance: Concordance between phenotypic and genotypic test results. Tuberculosis 89: 448-452.
26. Vasanthi N, Natarajan A, Manupriya S, Muthuraj M, Usharani B, et al. (2010) Characterization of Emb CB Genes Associated with Ethambutol Resistance in Human Isolates of Mycobacterium tuberculosis. International Journal of Microbiological Research 1(1): 14-21.
27. Piersimoni C, Olivieri A, Benacchio L, Scarparo C, (2006) Current Perspectives on Drug Susceptibility Testing of Mycobacterium tuberculosis Complex: the Automated Nonradiometric Systems. Journal of Clinical Microbiology, 44 (1): 20-28.
28. Vadwai V, Shetty A, Rodrigues C (2012) Multiplex allele specific PCR for rapid detection of extensively drug resistant tuberculosis. Tuberculosis, In press.
29. Ajbani K, Shetty A, Mehta A, Rodrigues C, (2011) Rapid diagnosis of Extensively Drug Resistant tuberculosis using a Reverse Line Blot Hybridization assay. Journal of Clinical Mirobiology 49(7): 2546-51.
30. Johnson R, Streicher E, Louw G, Warren RM, Van Helden PD, et al. (2006) Drug Resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. 8: 97-112.